Obtaining Complete Human Proteomes

Research output: Contribution to journalReviewResearchpeer-review

Standard

Obtaining Complete Human Proteomes. / Martinez-Val, Ana; Guzmán, Ulises H.; Olsen, Jesper V.

In: Annual Review of Genomics and Human Genetics, Vol. 23, 2022, p. 10.1-10.23.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Martinez-Val, A, Guzmán, UH & Olsen, JV 2022, 'Obtaining Complete Human Proteomes', Annual Review of Genomics and Human Genetics, vol. 23, pp. 10.1-10.23. https://doi.org/10.1146/annurev-genom-112921-024948

APA

Martinez-Val, A., Guzmán, U. H., & Olsen, J. V. (2022). Obtaining Complete Human Proteomes. Annual Review of Genomics and Human Genetics, 23, 10.1-10.23. https://doi.org/10.1146/annurev-genom-112921-024948

Vancouver

Martinez-Val A, Guzmán UH, Olsen JV. Obtaining Complete Human Proteomes. Annual Review of Genomics and Human Genetics. 2022;23:10.1-10.23. https://doi.org/10.1146/annurev-genom-112921-024948

Author

Martinez-Val, Ana ; Guzmán, Ulises H. ; Olsen, Jesper V. / Obtaining Complete Human Proteomes. In: Annual Review of Genomics and Human Genetics. 2022 ; Vol. 23. pp. 10.1-10.23.

Bibtex

@article{f6fa623ce1bb4296bfb44e799b8d910e,
title = "Obtaining Complete Human Proteomes",
abstract = "Proteins are the molecular effectors of the information encoded in the genome. Proteomics aims at understanding the molecular functions of proteins in their biological context. In contrast to transcriptomics and genomics, the study of proteomes provides deeper insight into the dynamic regulatory layers encoded at the protein level, such as posttranslational modifications, subcellular localization, cell signaling, and protein-protein interactions. Currently, mass spectrometry (MS)-based proteomics is the technology of choice for studying proteomes at a system-wide scale, contributing to clinical biomarker discovery and fundamental molecular biology. MS technologies are continuously being developed to fulfill the requirements of speed, resolution, and quantitative accuracy, enabling the acquisition of comprehensive proteomes. In this review, we present how MS technology and acquisition methods have evolved to meet the requirements of cutting-edge proteomics research, which is describing the human proteome and its dynamic posttranslational modifications with unprecedented depth. Finally, we provide a perspective on studying proteomes at single-cell resolution. Expected final online publication date for the Annual Review of Genomics and Human Genetics, Volume 23 is October 2022. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates. ",
author = "Ana Martinez-Val and Guzm{\'a}n, {Ulises H.} and Olsen, {Jesper V.}",
year = "2022",
doi = "10.1146/annurev-genom-112921-024948",
language = "English",
volume = "23",
pages = "10.1--10.23",
journal = "Annual Review of Genomics and Human Genetics",
issn = "1527-8204",
publisher = "Annual Reviews, inc.",

}

RIS

TY - JOUR

T1 - Obtaining Complete Human Proteomes

AU - Martinez-Val, Ana

AU - Guzmán, Ulises H.

AU - Olsen, Jesper V.

PY - 2022

Y1 - 2022

N2 - Proteins are the molecular effectors of the information encoded in the genome. Proteomics aims at understanding the molecular functions of proteins in their biological context. In contrast to transcriptomics and genomics, the study of proteomes provides deeper insight into the dynamic regulatory layers encoded at the protein level, such as posttranslational modifications, subcellular localization, cell signaling, and protein-protein interactions. Currently, mass spectrometry (MS)-based proteomics is the technology of choice for studying proteomes at a system-wide scale, contributing to clinical biomarker discovery and fundamental molecular biology. MS technologies are continuously being developed to fulfill the requirements of speed, resolution, and quantitative accuracy, enabling the acquisition of comprehensive proteomes. In this review, we present how MS technology and acquisition methods have evolved to meet the requirements of cutting-edge proteomics research, which is describing the human proteome and its dynamic posttranslational modifications with unprecedented depth. Finally, we provide a perspective on studying proteomes at single-cell resolution. Expected final online publication date for the Annual Review of Genomics and Human Genetics, Volume 23 is October 2022. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.

AB - Proteins are the molecular effectors of the information encoded in the genome. Proteomics aims at understanding the molecular functions of proteins in their biological context. In contrast to transcriptomics and genomics, the study of proteomes provides deeper insight into the dynamic regulatory layers encoded at the protein level, such as posttranslational modifications, subcellular localization, cell signaling, and protein-protein interactions. Currently, mass spectrometry (MS)-based proteomics is the technology of choice for studying proteomes at a system-wide scale, contributing to clinical biomarker discovery and fundamental molecular biology. MS technologies are continuously being developed to fulfill the requirements of speed, resolution, and quantitative accuracy, enabling the acquisition of comprehensive proteomes. In this review, we present how MS technology and acquisition methods have evolved to meet the requirements of cutting-edge proteomics research, which is describing the human proteome and its dynamic posttranslational modifications with unprecedented depth. Finally, we provide a perspective on studying proteomes at single-cell resolution. Expected final online publication date for the Annual Review of Genomics and Human Genetics, Volume 23 is October 2022. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.

U2 - 10.1146/annurev-genom-112921-024948

DO - 10.1146/annurev-genom-112921-024948

M3 - Review

C2 - 35440146

VL - 23

SP - 10.1-10.23

JO - Annual Review of Genomics and Human Genetics

JF - Annual Review of Genomics and Human Genetics

SN - 1527-8204

ER -

ID: 311124594